10 Groundbreaking Studies Using 3D Adipose Tissue Models (2020-2025)
Obesity and its related metabolic diseases, such as type 2 diabetes, represent a growing global health
Liver
SCIENTIFIC POSTER — Charting new paths in adipose tissue organoid development via stromal fraction
Authors: Mathilde Cadoux, PhD; Emilie Ouanounou; Ghofrane Ben Messaoud; Hadhemi Mejri; Julius Elliot Nyegaard Grothen, PhD;
From 2D to 3D: Restoring in vitro liver models functions
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In vitro liver models in drug discovery: Main models, advantages and use cases
In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,
Top 10 Breakthrough Studies Using Liver Organoids and Liver-on-Chip for Drug Discovery (2024-2025)
Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models
Liver-on-Chip Platforms: Recreating Human Physiology for Predictive Drug Development
Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of
Liver Organoids in Drug Discovery: 3D Cell Culture Models Transforming Toxicity Testing and Personalized Medicine
The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional
Organoids for Lipid Metabolism: Organoid and Organ-on-Chip Models in Metabolic Disease Research
Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty
Adipose Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metabolic Research
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Animal Testing Landscape 2025
About this white paper Animal testing has played a crucial role in medical advancements, leading to
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!